ELOXX PHARMACEUTICALS, INC. Shareholders' Equity
ELOXX PHARMACEUTICALS, INC. (ELOX) had Shareholders' Equity of $46.42 million as of 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $46.42M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$7.58M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$11.91M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$27.90M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $46.42M S-1 · filed 2026-09-11 | |
| 2026-03-31 | -$7.58M S-1 · filed 2026-09-11 | |
| 2025-12-31 | -$11.91M S-1 · filed 2026-09-11 | |
| 2025-06-30 | -$27.90M S-1 · filed 2026-09-11 | |
| 2025-03-31 | -$26.02M S-1 · filed 2026-09-11 | |
| 2024-12-31 | -$24.34M S-1 · filed 2026-09-11 | |
| 2023-12-31 | -$22.60M S-1 · filed 2026-09-11 | |
| 2023-09-30 | -$20.05M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$18.60M 10-Q · filed 2023-11-13 | |
| 2023-03-31 | $16.29M 10-Q · filed 2023-11-13 | -$16.29M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$10.66M S-1 · filed 2026-09-11 | |
| 2022-09-30 | -$4.98M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.81M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $11.69M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $22.38M 10-Q · filed 2023-11-13 | |
| 2021-09-30 | $33.00M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $40.64M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $2.75M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $10.23M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $15.08M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $20.29M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $26.26M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $36.21M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $45.23M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $55.22M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $34.43M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $42.91M 10-K · filed 2022-03-30 | |
| 2018-09-30 | $51.46M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $59.92M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $13.51M 10-Q · filed 2019-11-06 | $13.50M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $21.36M 10-K · filed 2021-03-12 | |
| 2017-09-30 | $3.31M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $871.21K 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $2.58M 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $610.00K 10-K · filed 2020-03-06 | $2.84M 10-Q · filed 2017-02-10 |
| 2016-09-30 | $3.63M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.56M 10-K · filed 2017-10-13 | |
| 2016-03-31 | $5.64M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $643.00K 10-K · filed 2019-03-14 | $8.72M 10-Q · filed 2016-02-16 |
| 2015-09-30 | $12.51M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $12.22M 10-K · filed 2017-10-13 | |
| 2015-03-31 | $11.21M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $2.77M 10-K · filed 2018-03-16 | $11.94M 10-Q · filed 2015-02-17 |
| 2014-09-30 | $22.43M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $27.49M 10-K · filed 2017-10-13 | |
| 2014-03-31 | $9.80M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $7.72M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $2.12M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.79M 10-K · filed 2016-10-13 | |
| 2013-03-31 | $3.31M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.58M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $2.63M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $3.45M 10-K · filed 2015-10-09 | |
| 2012-03-31 | $4.60M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $2.83M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $3.93M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $4.52M 10-K · filed 2014-09-29 | |
| 2010-06-30 | $7.98M 10-K · filed 2013-09-11 | |
| 2009-06-30 | $5.67M 10-K · filed 2013-09-11 | |
| 2008-06-30 | $9.84M 10-K · filed 2013-09-11 | |
| 2007-06-30 | $2.69M 10-K · filed 2013-09-11 | |
| 2006-06-30 | $2.95M 10-K · filed 2013-09-11 | |
| 2005-06-30 | $5.59M 10-K · filed 2013-09-11 | |
| 2004-06-30 | $4.73M 10-K · filed 2013-09-11 | |
| 2003-06-30 | $2.86M 10-K · filed 2013-09-11 | |
| 2002-06-30 | $4.79M 10-K · filed 2013-09-11 | |
| 2001-06-30 | -$206.71K 10-K · filed 2013-09-11 | |
| 2000-06-30 | $1.52M 10-K · filed 2013-09-11 | |
| 1999-06-30 | $912.17K 10-K · filed 2013-09-11 | |
| 1998-06-30 | $0.00 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |